Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 453

1.

Angioplasty with stenting for Budd-Chiari syndrome.

Payancé A, Plessier A, Valla D, Rautou PE.

Lancet Gastroenterol Hepatol. 2019 Sep;4(9):657-659. doi: 10.1016/S2468-1253(19)30224-9. Epub 2019 Jul 3. No abstract available.

PMID:
31279648
2.

Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study.

Baiges A, Turon F, Simón-Talero M, Tasayco S, Bueno J, Zekrini K, Plessier A, Franchi-Abella S, Guerin F, Mukund A, Eapen CE, Goel A, Shyamkumar NK, Coenen S, De Gottardi A, Majumdar A, Onali S, Shukla A, Carrilho FJ, Nacif L, Primignani M, Tosetti G, La Mura V, Nevens F, Witters P, Tripathi D, Tellez L, Martínez J, Álvarez-Navascués C, Fraile López ML, Procopet B, Piscaglia F, de Koning B, Llop E, Romero-Cristobal M, Tjwa E, Monescillo-Francia A, Senzolo M, Perez-LaFuente M, Segarra A, Sarin SK, Hernández-Gea V, Patch D, Laleman W, Hartog H, Valla D, Genescà J, García-Pagán JC; REHEVASC, VALDIG an EASL consortium, Abernethy group.

Hepatology. 2019 Jun 18. doi: 10.1002/hep.30817. [Epub ahead of print]

PMID:
31211875
3.

Letter: nonselective beta-blockers, endoscopic therapy and portal vein thrombosis in cirrhosis. Authors' reply.

Nery F, Valla D.

Aliment Pharmacol Ther. 2019 May;49(10):1371-1372. doi: 10.1111/apt.15262. No abstract available.

PMID:
31016772
4.

Porto-sinusoidal vascular disease: proposal and description of a novel entity.

De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad SD, Vilgrain V, Hernandez-Gea V, Nery F, Plessier A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan JC; VALDIG group.

Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411. doi: 10.1016/S2468-1253(19)30047-0.

PMID:
30957754
5.

Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.

Günther S, Perros F, Rautou PE, Girerd B, Ghigna MR, Cazals-Hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D.

Am J Pathol. 2019 Jun;189(6):1159-1175. doi: 10.1016/j.ajpath.2019.02.007. Epub 2019 Mar 26. Review.

PMID:
30926335
6.

Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study.

Elkrief L, Ferrusquia-Acosta J, Payancé A, Moga L, Tellez L, Praktiknjo M, Procopet B, Farcau O, De Lédinghen V, Yuldashev R, Tabchouri N, Barbier L, Dumortier J, Menahem B, Magaz M, Hernández-Gea V, Albillos A, Trebicka J, Spahr L, De Gottardi A, Plessier A, Valla D, Rubbia-Brandt L, Toso C, Bureau C, Garcia-Pagan JC, Rautou PE; for VALDIG, an EASL consortium.

Hepatology. 2019 Sep;70(3):911-924. doi: 10.1002/hep.30628. Epub 2019 May 21.

PMID:
30924941
7.

Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study.

Nery F, Correia S, Macedo C, Gandara J, Lopes V, Valadares D, Ferreira S, Oliveira J, Gomes MT, Lucas R, Rautou PE, Miranda HP, Valla D.

Aliment Pharmacol Ther. 2019 Mar;49(5):582-588. doi: 10.1111/apt.15137. Epub 2019 Jan 22.

PMID:
30671978
8.

Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.

Van Wettere M, Purcell Y, Bruno O, Payancé A, Plessier A, Rautou PE, Cazals-Hatem D, Valla D, Vilgrain V, Ronot M.

J Hepatol. 2019 Jun;70(6):1123-1132. doi: 10.1016/j.jhep.2019.01.009. Epub 2019 Jan 14.

PMID:
30654065
9.

Dataset on the TIC-MOC cruise onboard the R/V Hespérides, March 2015, Brazil-Malvinas Confluence.

Orúe-Echevarría D, Pelegrí JL, Alonso-González IJ, Benítez-Barrios VM, De La Fuente P, Emelianov M, Gasser M, Herrero C, Isern-Fontanet J, Peña-Izquierdo J, Ramírez-Garrido S, Rosell-Fieschi M, Salvador J, Saraceno M, Valla D, Vidal M.

Data Brief. 2018 Dec 6;22:185-194. doi: 10.1016/j.dib.2018.12.004. eCollection 2019 Feb.

10.

Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.

Lejealle C, Paradis V, Bruno O, de Raucourt E, Francoz C, Soubrane O, Lebrec D, Bedossa P, Valla D, Mal H, Vilgrain V, Durand F, Rautou PE.

Chest. 2019 Jan;155(1):123-136. doi: 10.1016/j.chest.2018.09.017. Epub 2018 Oct 4.

PMID:
30292761
11.

Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.

Sartoris R, Rautou PE, Elkrief L, Pollorsi G, Durand F, Valla D, Spahr L, Terraz S, Soubrane O, Cauchy F, Vilgrain V, Ronot M.

Radiology. 2018 Dec;289(3):698-707. doi: 10.1148/radiol.2018181131. Epub 2018 Sep 4.

PMID:
30179109
12.

Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.

Moreau R, Elkrief L, Bureau C, Perarnau JM, Thévenot T, Saliba F, Louvet A, Nahon P, Lannes A, Anty R, Hillaire S, Pasquet B, Ozenne V, Rudler M, Ollivier-Hourmand I, Robic MA, d'Alteroche L, Di Martino V, Ripault MP, Pauwels A, Grangé JD, Carbonell N, Bronowicki JP, Payancé A, Rautou PE, Valla D, Gault N, Lebrec D; NORFLOCIR Trial Investigators.

Gastroenterology. 2018 Dec;155(6):1816-1827.e9. doi: 10.1053/j.gastro.2018.08.026. Epub 2018 Aug 23.

13.

Pregnancy in idiopathic non-cirrhotic portal hypertension: A multicentric study on maternal and fetal management and outcome.

Andrade F, Shukla A, Bureau C, Senzolo M, D'Alteroche L, Heurgué A, Garcia-Pagan JC, Turon F, Oberti F, Tripathi D, Roux O, Ceccaldi PF, de Raucourt E, Payancé A, Valla D, Plessier A, Rautou PE; VALDIG investigators.

J Hepatol. 2018 Dec;69(6):1242-1249. doi: 10.1016/j.jhep.2018.08.007. Epub 2018 Aug 21.

PMID:
30138688
14.

Transient portal vein thrombosis in liver cirrhosis.

Qi X, Guo X, Yoshida EM, Méndez-Sánchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC.

BMC Med. 2018 Jun 5;16(1):83. doi: 10.1186/s12916-018-1069-8. Review.

15.

The epidemiology of Budd-Chiari syndrome in France.

Ollivier-Hourmand I, Allaire M, Goutte N, Morello R, Chagneau-Derrode C, Goria O, Dumortier J, Cervoni JP, Dharancy S, Ganne-Carrié N, Bureau C, Carbonell N, Abergel A, Nousbaum JB, Anty R, Barraud H, Ripault MP, De Ledinghen V, Minello A, Oberti F, Radenne S, Bendersky N, Farges O, Archambeaud I, Guillygomarc'h A, Ecochard M, Ozenne V, Hilleret MN, Nguyen-Khac E, Dauvois B, Perarnau JM, Lefilliatre P, Raabe JJ, Doffoel M, Becquart JP, Saillard E, Valla D, Dao T, Plessier A; French Network for Vascular Disorders of the Liver.

Dig Liver Dis. 2018 Sep;50(9):931-937. doi: 10.1016/j.dld.2018.04.004. Epub 2018 Apr 12.

PMID:
29803757
16.

Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis.

Payancé A, Silva-Junior G, Bissonnette J, Tanguy M, Pasquet B, Levi C, Roux O, Nekachtali O, Baiges A, Hernández-Gea V, Laouénan C, Lebrec D, Albuquerque M, Paradis V, Moreau R, Valla D, Durand F, Boulanger CM, Garcia-Pagan JC, Rautou PE.

Hepatology. 2018 Oct;68(4):1508-1518. doi: 10.1002/hep.29903. Epub 2018 May 21.

PMID:
29603327
17.

Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.

Valla DC, Cazals-Hatem D.

Virchows Arch. 2018 Jul;473(1):3-13. doi: 10.1007/s00428-018-2331-3. Epub 2018 Mar 24. Review.

PMID:
29572606
18.

Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.

Stepanova M, Nader F, Bureau C, Adebayo D, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rossi S, MacDonald S, Capel J, Jalan R, Younossi ZM.

Qual Life Res. 2018 Jun;27(6):1513-1520. doi: 10.1007/s11136-018-1813-8. Epub 2018 Feb 19.

PMID:
29460201
19.

Benign and malignant hepatocellular lesions in patients with vascular liver diseases.

Vilgrain V, Paradis V, Van Wettere M, Valla D, Ronot M, Rautou PE.

Abdom Radiol (NY). 2018 Aug;43(8):1968-1977. doi: 10.1007/s00261-018-1502-7.

PMID:
29460040
20.

Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949].

Bureau C, Adebayo D, de Rieu MC, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Abbadi R, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R.

J Hepatol. 2018 Mar;68(3):630. doi: 10.1016/j.jhep.2017.12.017. Epub 2018 Feb 1. No abstract available.

PMID:
29395458
21.

Endothelial JAK2V617F does not enhance liver lesions in mice with Budd-Chiari syndrome.

Poisson J, Hilscher MB, Tanguy M, Hammoutene A, Boulanger CM, Villeval JL, Simonetto DA, Valla D, Shah VH, Rautou PE.

J Hepatol. 2018 May;68(5):1086-1087. doi: 10.1016/j.jhep.2018.01.010. Epub 2018 Jan 31. No abstract available.

PMID:
29360553
22.

Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.

Qi X, Valla DC, Guo X.

Gastroenterology. 2018 Feb;154(3):760-761. doi: 10.1053/j.gastro.2017.09.057. Epub 2018 Jan 17. No abstract available.

PMID:
29351830
23.

Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis.

Elkrief L, Ronot M, Andrade F, Dioguardi Burgio M, Issoufaly T, Zappa M, Roux O, Bissonnette J, Payancé A, Lebrec D, Francoz C, Soubrane O, Valla D, Durand F, Vilgrain V, Castera L, Rautou PE.

Aliment Pharmacol Ther. 2018 Mar;47(5):621-630. doi: 10.1111/apt.14488. Epub 2018 Jan 11.

24.

Things fall apart with hepatocellular carcinoma and direct-acting antivirals.

Kutala B, Valla D, Marcellin P.

Expert Opin Drug Saf. 2018 Feb;17(2):107-109. doi: 10.1080/14740338.2018.1404026. Epub 2017 Nov 14. No abstract available.

PMID:
29137488
25.

Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units.

Laurent L, Lemaitre C, Minello A, Plessier A, Lamblin G, Poujol-Robert A, Gervais-Hasenknopf A, Pariente EA, Belenotti P, Mostefa-Kara N, Sogni P, Legrand M, Cournac JM, Tamion F, Savoye G, Bedossa P, Valla DC, Vilgrain V, Goria O.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1070-1076. doi: 10.1111/apt.14367. Epub 2017 Oct 11.

26.

Quantitative Imaging in Diffuse Liver Diseases.

Van Beers BE, Garteiser P, Leporq B, Rautou PE, Valla D.

Semin Liver Dis. 2017 Aug;37(3):243-258. doi: 10.1055/s-0037-1603651. Epub 2017 Aug 28. No abstract available.

PMID:
28847035
27.

Mutations in the novel gene FOPV are associated with familial autosomal dominant and non-familial obliterative portal venopathy.

Besmond C, Valla D, Hubert L, Poirier K, Grosse B, Guettier C, Bernard O, Gonzales E, Jacquemin E.

Liver Int. 2018 Feb;38(2):358-364. doi: 10.1111/liv.13547. Epub 2017 Sep 12.

PMID:
28792652
28.

1.15 PW-850 J compressed beam demonstration using the PETAL facility.

Blanchot N, Béhar G, Chapuis JC, Chappuis C, Chardavoine S, Charrier JF, Coïc H, Damiens-Dupont C, Duthu J, Garcia P, Goossens JP, Granet F, Grosset-Grange C, Guerin P, Hebrard B, Hilsz L, Lamaignere L, Lacombe T, Lavastre E, Longhi T, Luce J, Macias F, Mangeant M, Mazataud E, Minou B, Morgaint T, Noailles S, Neauport J, Patelli P, Perrot-Minnot E, Present C, Remy B, Rouyer C, Santacreu N, Sozet M, Valla D, Laniesse F.

Opt Express. 2017 Jul 24;25(15):16957-16970. doi: 10.1364/OE.25.016957.

PMID:
28789195
29.

Budd-Chiari syndrome/hepatic venous outflow tract obstruction.

Valla DC.

Hepatol Int. 2018 Feb;12(Suppl 1):168-180. doi: 10.1007/s12072-017-9810-5. Epub 2017 Jul 6. Review.

PMID:
28685257
30.

Reply to: "Calreticulin mutations and their importance in Budd-Chiari syndrome".

Poisson J, Turon F, Marzac C, Valla DC, Garcia-Pagan JC, Rautou PE.

J Hepatol. 2017 Nov;67(5):1112-1113. doi: 10.1016/j.jhep.2017.06.018. Epub 2017 Jun 27. No abstract available.

PMID:
28662846
31.

Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.

Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R.

J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21. Erratum in: J Hepatol. 2018 Jan 29;:.

PMID:
28645737
32.

Large oesophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy.

Calès P, Sacher-Huvelin S, Valla D, Bureau C, Olivier A, Oberti F, Boursier J, Galmiche JP; multicenter group VO-VCO.

Liver Int. 2018 Jan;38(1):84-93. doi: 10.1111/liv.13497. Epub 2017 Jul 7.

PMID:
28622450
33.

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.

Poisson J, Plessier A, Kiladjian JJ, Turon F, Cassinat B, Andreoli A, De Raucourt E, Goria O, Zekrini K, Bureau C, Lorre F, Cervantes F, Colomer D, Durand F, Garcia-Pagan JC, Casadevall N, Valla DC, Rautou PE, Marzac C; French national network for vascular liver diseases.

J Hepatol. 2017 Sep;67(3):501-507. doi: 10.1016/j.jhep.2017.04.021. Epub 2017 May 5.

PMID:
28483676
34.

Thrombin generation in patients with non-cirrhotic vascular liver diseases treated or not treated with vitamin K antagonist.

de Raucourt E, Kuadjovi C, Rautou PE, Ajzenberg N, Boudaoud L, Valla D, Plessier A.

Thromb Res. 2017 Jul;155:28-30. doi: 10.1016/j.thromres.2017.05.002. Epub 2017 May 2. No abstract available.

PMID:
28478207
35.

Reply.

Sarin SK, Choudhury A, Philips CA, Kamath P, Maruyama H, Valla D.

Gastroenterology. 2017 Apr;152(5):1247-1248. doi: 10.1053/j.gastro.2017.03.003. Epub 2017 Mar 6. No abstract available.

PMID:
28268095
36.

A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.

Bissonnette J, Altamirano J, Devue C, Roux O, Payancé A, Lebrec D, Bedossa P, Valla D, Durand F, Ait-Oufella H, Sancho-Bru P, Caballeria J, Ginès P, Boulanger CM, Bataller R, Rautou PE.

Hepatology. 2017 Aug;66(2):555-563. doi: 10.1002/hep.29080. Epub 2017 Jun 22.

PMID:
28120471
37.

Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome.

Weiss E, Rautou PE, Fasseu M, Giabicani M, de Chambrun M, Wan J, Minsart C, Gustot T, Couvineau A, Maiwall R, Hurtado-Nedelec M, Pilard N, Lebrec D, Valla D, Durand F, de la Grange P, Monteiro RC, Paugam-Burtz C, Lotersztajn S, Moreau R.

J Hepatol. 2017 May;66(5):930-941. doi: 10.1016/j.jhep.2016.12.008. Epub 2016 Dec 28.

PMID:
28040548
38.

Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome.

Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V.

Radiology. 2017 Apr;283(1):280-292. doi: 10.1148/radiol.2016152641. Epub 2016 Oct 31.

PMID:
27797679
39.

Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.

De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J, Puente A, Müllhaupt B, Navascuès C, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek FWG, Valla D, Garcia-Pagan JC; VALDIG Investigators.

Liver Int. 2017 May;37(5):694-699. doi: 10.1111/liv.13285. Epub 2016 Nov 19.

PMID:
27778440
40.

Arterial hypertension as an uninvited player in hepatic stiffness?

Ratziu V, Valla D, Rautou PE.

Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G942-G944. doi: 10.1152/ajpgi.00276.2016. Epub 2016 Oct 20. No abstract available.

41.

LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis.

Odena G, Chen J, Lozano JJ, Altamirano J, Rodrigo-Torres D, Affo S, Morales-Ibanez O, Matsushita H, Zou J, Dumitru R, Caballeria J, Gines P, Arroyo V, You M, Rautou PE, Valla D, Crews F, Seki E, Sancho-Bru P, Bataller R.

Sci Rep. 2016 Oct 18;6:35610. doi: 10.1038/srep35610.

42.

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.

Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, Xu H, Mancuso A, Zhang W, Han X, Valla DC, Fan D.

Aliment Pharmacol Ther. 2016 Dec;44(11-12):1152-1167. doi: 10.1111/apt.13815. Epub 2016 Oct 13. Review.

43.

Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis.

Sarin SK, Philips CA, Kamath PS, Choudhury A, Maruyama H, Nery FG, Valla DC.

Gastroenterology. 2016 Oct;151(4):574-577.e3. doi: 10.1053/j.gastro.2016.08.033. Epub 2016 Aug 27. No abstract available.

PMID:
27575821
44.

Liver sinusoidal endothelial cells: Physiology and role in liver diseases.

Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D, Rautou PE.

J Hepatol. 2017 Jan;66(1):212-227. doi: 10.1016/j.jhep.2016.07.009. Epub 2016 Jul 14. Review.

PMID:
27423426
45.

Safety of supramesocolic surgery in patients with portal cavernoma without portal vein decompression. Large single centre experience.

Dokmak S, Aussilhou B, Sauvanet A, Lévy P, Plessier A, Ftériche FS, Farges O, Vilgrain V, Valla DC, Belghiti J.

HPB (Oxford). 2016 Jul;18(7):623-9. doi: 10.1016/j.hpb.2016.05.009. Epub 2016 Jun 16.

46.

Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.

Perlemuter G, Cacoub P, Valla D, Guyader D, Saba B, Batailler C, Moore K.

CNS Drugs. 2016 Sep;30(9):877-88. doi: 10.1007/s40263-016-0351-6.

PMID:
27342740
47.

Editorial: short-length stenoses of hepatic venous outflow tract - an Asian specificity?

Valla DC, Payancé A.

Aliment Pharmacol Ther. 2016 Jul;44(2):200-1. doi: 10.1111/apt.13656. No abstract available.

48.

Sinusoidal obstruction syndrome.

Valla DC, Cazals-Hatem D.

Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):378-85. doi: 10.1016/j.clinre.2016.01.006. Epub 2016 Mar 30. Review.

49.

Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.

Bissonnette J, Garcia-Pagán JC, Albillos A, Turon F, Ferreira C, Tellez L, Nault JC, Carbonell N, Cervoni JP, Abdel Rehim M, Sibert A, Bouchard L, Perreault P, Trebicka J, Trottier-Tellier F, Rautou PE, Valla DC, Plessier A.

Hepatology. 2016 Jul;64(1):224-31. doi: 10.1002/hep.28547. Epub 2016 May 13.

PMID:
26990687
50.

Diabetes mellitus in patients with cirrhosis: clinical implications and management.

Elkrief L, Rautou PE, Sarin S, Valla D, Paradis V, Moreau R.

Liver Int. 2016 Jul;36(7):936-48. doi: 10.1111/liv.13115. Epub 2016 Apr 4. Review.

PMID:
26972930

Supplemental Content

Support Center